Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ossur hf Reiterates FY 2013 Financial Guidance


Wednesday, 24 Jul 2013 10:00am EDT 

Ossur hf announced that the Company's Management reiterates its previous guidance for the fiscal year 2013. LCY organic sales growth was initially expected to be in the range of 2-4% and adjusted EBITDA margin 18-19%. As communicated in the Q1 2013 report, Management expects the results for the fiscal year 2013 to be in the lower end of the guided range, both in terms of sales and EBITDA. 

Company Quote

356.0
 --
18 Dec 2014